Filing Details

Accession Number:
0001127602-20-022170
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-07-28 16:06:54
Reporting Period:
2020-07-24
Accepted Time:
2020-07-28 16:06:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
97745 Thermo Fisher Scientific Inc. TMO Measuring & Controlling Devices, Nec (3829) 042209186
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1387890 Mark Stevenson 168 Third Avenue
Waltham MA 02451
Executive Vice President & Coo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-07-24 25,000 $124.28 73,621 No 4 M Direct
Common Stock Disposition 2020-07-24 400 $399.69 73,221 No 4 S Direct
Common Stock Disposition 2020-07-24 300 $401.03 72,921 No 4 S Direct
Common Stock Disposition 2020-07-24 1,300 $402.50 71,621 No 4 S Direct
Common Stock Disposition 2020-07-24 5,363 $403.54 66,258 No 4 S Direct
Common Stock Disposition 2020-07-24 8,037 $404.48 58,221 No 4 S Direct
Common Stock Disposition 2020-07-24 5,969 $405.55 52,252 No 4 S Direct
Common Stock Disposition 2020-07-24 3,631 $406.31 48,621 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2020-07-24 25,000 $0.00 25,000 $124.28
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2021-02-26 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 53,959 Indirect By Stevenson 2010 Living Trust
Common Stock 477 Indirect By 401(k)
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 3, 2020.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $399.65 to $399.81, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6), (7) and (8) to this Form 4.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $400.84 to $401.12, inclusive.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $401.96 to $402.95, inclusive.
  5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $402.97 to $403.96, inclusive.
  6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $403.97 to $404.90, inclusive.
  7. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $404.98 to $405.97, inclusive.
  8. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $405.995 to $406.90, inclusive.
  9. Between August 27, 2019 and July 24, 2020, the reporting person disposed .01 shares of TMO common stock under the TMO 401(k) plan.
  10. The option vested in four equal installments on February 26, 2015, 2016, 2017, and 2018.